A detailed history of Dt Investment Partners, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Dt Investment Partners, LLC holds 45 shares of CTLT stock, worth $2,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Holding current value
$2,856
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$56.16 - $60.96 $2,527 - $2,743
45 New
45 $2,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Dt Investment Partners, LLC Portfolio

Follow Dt Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dt Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dt Investment Partners, LLC with notifications on news.